DiaSorin Completes $1.8bn acquisition of Luminex
Source : Medtech Insight
Italian Diagnostics company DiaSorin SpA has completed its planned $1.8bn acquisition of Luminex Corporation, the company announced 14 July.
Under the terms of the deal announced in April, DiaSorin will...
FDA Issues New EUA Product Codes To Track Adverse Events, Imports
Source : Medtech Insight
The US Food and Drug Administration has published new product codes for emergency use authorized (EUA) products that have been allowed on the market during the COVID-19 pandemic.
The agency says...
MHRA Must Seize UK Digital And Diagnostics Opportunity: ABHI Perspectives On Enabling Regulation – Part 2
Source : Medtech Insight
The starting gun is yet to be fired for the UK Medicines and Healthcare products Regulatory Agency’s (MHRA) consultation on the UKCA marking, which had initially been expected in early...
FDA Cautions EUA-Holders They Have Same MDR Reporting Responsibilities As Other Manufacturers
Source : Medtech Insight
Manufactures that have an emergency use authorized (EUA) product on the market due to the COVID-19 pandemic are still bound by the same regulations as other device-makers to notify regulators...
Generics Industry Fails To Match Last Year’s Growth In First Quarter
Source : 'Generics Bulletin'
After experiencing an exceptionally strong performance due to COVID-induced stockpiling and panic buying in the first quarter of last year, the generics industry largely saw revenues drop due to pandemic-related...